Education
About Us
Working with TipRanks
Follow Us
Rockwell Medical Technologies (RMTI)
NASDAQ:RMTI
Earnings Data
Report Date
May 12, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.05Last Year’s EPS
-0.06Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 20, 2025
|% Change Since: -40.34%
|Next Earnings Date:May 12, 2025
Earnings Call Sentiment|Neutral
Rockwell Medical had a successful 2024 with record sales and improved margins, but faces significant challenges in 2025 due to the loss of its largest customer. The company is actively pursuing new opportunities to counter the revenue decline.Company Guidance
During Rockwell Medical's fourth quarter and full year 2024 results conference call, the company provided guidance for 2025, emphasizing the year as a transition phase due to a significant customer transitioning to another supplier, which is expected to reduce revenue by approximately $34 million. Despite this, Rockwell projects net sales between $65 million and $70 million, with a gross margin of 16% to 18%, and adjusted EBITDA ranging from negative $500,000 to positive $500,000. The company achieved over $100 million in net sales for 2024, with a 21% year-over-year increase, and improved its gross margin to 17%. Rockwell also recorded net sales of $24.7 million in Q4 2024, marking a 12% increase from the same period in 2023, while achieving profitability on an adjusted EBITDA basis for the first time in its history. The company's strategic initiatives for 2025 include diversifying its customer base, expanding its product portfolio, and optimizing business operations, with plans to target additional customers and pursue new business development opportunities.Record Net Sales and Profitability
For the full year 2024, Rockwell Medical achieved net sales of $101.5 million, marking a 21% increase from 2023, and achieved profitability on an adjusted EBITDA basis for the first time in its history.
Gross Margin Improvement
Gross margin improved from 10% in 2023 to 17% in 2024, driven by price increases, premium-priced product orders, and operational efficiencies.
Successful Strategic Acquisitions
Rockwell Medical acquired dialysis concentrates assets from Evoqua in 2023, which contributed significantly to top-line revenue and market presence.
Expansion in International Markets
The company now sells products in over 30 countries, with a notable expansion in the Philippines through Nephro Group Dialysis Centers.
New Product and Customer Wins
Introduced a convenience pack for home and acute care markets, and entered into long-term agreements with major dialysis product providers and distributors like B. Braun and Nipro Medical Corporation.
---
RMTI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
RMTI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 20, 2025 | $1.76 | $1.40 | -20.45% |
| Nov 12, 2024 | $4.65 | $2.83 | -39.14% |
| Aug 08, 2024 | $1.77 | $2.14 | +20.90% |
| May 14, 2024 | $1.70 | $1.70 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Rockwell Medical Technologies (RMTI) report earnings?
Rockwell Medical Technologies (RMTI) is schdueled to report earning on May 12, 2025, TBA Not Confirmed.
What is Rockwell Medical Technologies (RMTI) earnings time?
Rockwell Medical Technologies (RMTI) earnings time is at May 12, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is RMTI EPS forecast?
RMTI EPS forecast for the fiscal quarter 2025 (Q1) is -0.05.
---